<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>研如玉 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-06T20:31:18+08:00</updated>
  <subtitle>新药开发立项，注册，BD，法规政策解读，市场动态和市场分析，工艺改进优化，质量提升</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>中国参比制剂发展简史及参比制剂申报受理</title>
    <updated>2020-11-01T22:27:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/NiOnD94uyuKzY7nWrAp9Tw</id>
    <link href="https://mp.weixin.qq.com/s/NiOnD94uyuKzY7nWrAp9Tw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【十四季学术沙龙PPT】从当前市场变化看 OTC药物的研发立项</title>
    <updated>2020-10-25T15:58:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/mvQ3yV5OyXnpb3_D049X0Q</id>
    <link href="https://mp.weixin.qq.com/s/mvQ3yV5OyXnpb3_D049X0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【十四季学术沙龙PPT】原料药国际注册最新进展</title>
    <updated>2020-10-22T12:25:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-22:/s/LPTM6tPvxc9Sftzlb9ywkA</id>
    <link href="https://mp.weixin.qq.com/s/LPTM6tPvxc9Sftzlb9ywkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【十四季学术沙龙PPT】仿制药制剂开发细节关注点</title>
    <updated>2020-10-19T12:44:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/66gAq7_jMbAXsvLiToUMvw</id>
    <link href="https://mp.weixin.qq.com/s/66gAq7_jMbAXsvLiToUMvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【大力推荐】支持混悬滴眼液产品开发的生理药代动力学模型</title>
    <updated>2020-10-08T21:09:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-08:/s/lVeUih1rgZjceGhPMNLscQ</id>
    <link href="https://mp.weixin.qq.com/s/lVeUih1rgZjceGhPMNLscQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【南京、南京】第十四季医药信息开发群群友学术研讨会最终通知</title>
    <updated>2020-09-27T20:14:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-27:/s/JQ5AdIlEYsb4YgWwhE8iyQ</id>
    <link href="https://mp.weixin.qq.com/s/JQ5AdIlEYsb4YgWwhE8iyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美沙酮与抗病毒药物的药物相互作用研究：经验与教训</title>
    <updated>2020-09-24T19:33:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-24:/s/lJC6SprVssSjx-LhWyBnlA</id>
    <link href="https://mp.weixin.qq.com/s/lJC6SprVssSjx-LhWyBnlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药制造行业主要法律法律与主要政策</title>
    <updated>2020-09-21T21:32:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-21:/s/Z0zW3NlmsFrn0EdDaudMhA</id>
    <link href="https://mp.weixin.qq.com/s/Z0zW3NlmsFrn0EdDaudMhA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百家创新与改良型新药企都在关注哪些创新技术干货？PharmaCon2020带您一览</title>
    <updated>2020-09-21T21:32:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-21:/s/TSmprmeZdRqaGXSflLwuzA</id>
    <link href="https://mp.weixin.qq.com/s/TSmprmeZdRqaGXSflLwuzA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【大力推荐】使用体外和计算机模拟模型进行超出FDA现行标准的崩解试验的依据</title>
    <updated>2020-09-20T20:21:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-20:/s/AlTwCRkqIUIFSLwME9o7mw</id>
    <link href="https://mp.weixin.qq.com/s/AlTwCRkqIUIFSLwME9o7mw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【刷爆朋友圈】OTC大机遇：从国际OTC成熟产品看国内未被满足的机会</title>
    <updated>2020-09-18T18:47:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-18:/s/Mvu-80t5retYBuJto01TWA</id>
    <link href="https://mp.weixin.qq.com/s/Mvu-80t5retYBuJto01TWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>